Monthly Naltrexone Drug Wins FDA Approval (Join Together Online)
Vivitrol, an injectable, once-monthly version of the alcoholism drug naltrexone, has been approved by the U.S. Food and Drug Administration (FDA), the Associated Press reported April 14. Vivitrol was developed by Alkermes, Inc., and is marketed by Cephalon, Inc.

FDA OKs New Alcoholism Treatment (MedicineNet.com)
Title: FDA OKs New Alcoholism Treatment Category: Health News Created: 4/17/2006 Last Editorial Review: 4/17/2006